Merial invests US $70 million in Nanch...( that could cause actual results and dev...),Health

Date:10/11/2009

, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include those discussed or identified in the public filings with the SEC and the AMF made by sanofi-aventis, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in sanofi-aventis' annual report on Form 20-F for the year ended December 31, 2008. Other than as required by applicable law, sanofi-aventis does not undertake any obligation to update or revise any forward-looking information or statements.

SOURCE Merial

'/>"/>

SOURCE Merial Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. Kansas Invests Millions in Innovations to Improve Human Health and Launches Three National Bioscience Programs at BIO08
2. 7 Health Ventures Invests in Tulip Medical
3. Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Atritech Announces Completion of a $22 Million Equity Financing
6. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
7. EntreMed Raises $20 Million to Support Clinical Development Program
8. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
9. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
10. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
11. Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568